EyePoint Pharmaceuticals Receives Preliminary Extension to Pass-Through Payment Status for DEXYCU®

NEXT STORY
Children’s National Hospital and NIAID launch large study on long-term impacts of COVID-19 and MIS-C on kids
PREV STORY
Immuneering Appoints Michael Bookman as General Counsel and Secretary
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Endocyte Announces Presentation at the European Society for Medical Oncology (ESMO)

WEST LAFAYETTE, Ind., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader ...

author_avatar
NASDAQ Market News

Helsinn Group and Angelini support Satellite Symposium at MASCC/ISOO 2018 Annual Meeting

Helsinn Group and Angelini support Satellite Symposium at MASCC/ISOO 2018 Annual Meeting Leading cancer ...

author_avatar
NASDAQ Market News

Proteostasis Therapeutics Appoints Naimish Patel, M.D., C.M., and Elizabeth Tullis, M.D., FRCPC, to its Clinical Advisory Board

CAMBRIDGE, Mass., Sept. 28, 2016 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a biopharmaceutical ...

author_avatar
NASDAQ Market News